Beijing Balance Medical Technology Co.,Ltd. (SHA:688198)

Market Cap	14.13B -3.8%
Revenue (ttm)	630.37M +25.6%
Net Income	200.19M +36.8%
EPS	1.46 +36.4%
Shares Out	137.75M
PE Ratio	70.27
Forward PE	51.81
Dividend	0.80 (0.79%)
Ex-Dividend Date	May 29, 2025

Volume	216,748
Average Volume	354,090
Open	100.49
Previous Close	100.75
Day's Range	100.25 - 104.00
52-Week Range	95.28 - 132.94
Beta	0.25
RSI	44.65
Earnings Date	Apr 22, 2026

About SHA:688198

Beijing Balance Medical Technology Co.,Ltd. engages in the research and development, production, sale, and service of animal-derived implantable medical devices in China. The company offers artificial biological heart valves, bovine pericardial and porcine aortic valves; pulmonary valved conduit; tissue antigen removal processor, annuloplasty and valvuloplasty rings, and surgical biological patches; bovine pericardial valves, as well as pulmonary artery valved pipeline, outflow tract single flap patches, etc. Its products are used in heart valv...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2005
• Employees: 670
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688198

Financial Performance

In 2025, SHA:688198's revenue was 630.37 million, an increase of 25.60% compared to the previous year's 501.88 million. Earnings were 200.19 million, an increase of 36.81%.